Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-21

Clinical Trial Update: Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of tranexamic acid in spinal fusion surgery was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Exela Pharma Sciences, LLC. | Conditions: Spinal Fusion | Phase 3 | Status: TERMINATED | Results posted: 2021-06-21